To modernize and strengthen Federal efforts to improve ovarian cancer awareness, hereditary cancer risk assessment, access to genetic counseling and testing, and access to specialty care, and for other purposes.
Latest action (24 Sep 2026): Introduced
What this bill does
Generate a neutral, plain-English explanation of what this bill does, who it affects and what happens next — grounded in the official text.
Official summary
This bill is in the first stage of the legislative process. It was introduced into Congress on September 24, 2026. It will typically be considered by committee next before it is possibly sent on to the House or Senate as a whole.
Common questions
- What does H.R. 10544 do?
- This bill is in the first stage of the legislative process. It was introduced into Congress on September 24, 2026. It will typically be considered by committee next before it is possibly sent on to the House or Senate as a whole.
- Has H.R. 10544 become law?
- Not yet. As of 24 Sep 2026, H.R. 10544 is introduced.
- Who sponsored H.R. 10544?
- H.R. 10544 was sponsored by Rep. Rosa DeLauro [D-CT3] (Democrat-CT), with 0 cosponsors.
- What's the latest action on H.R. 10544?
- Introduced (24 Sep 2026).
Bill100 mirrors the public U.S. legislative record from Congress.gov and GovTrack and adds plain-English AI summaries. It is an information tool, not legal, compliance or lobbying advice, and it is not affiliated with the U.S. Congress or any government agency. AI summaries can simplify or omit detail — every bill links to the official source; verify there before you rely on it.